Karen Zylberman Email

VP, Head Pharmacovigilance Services and Medical Informatics . Phathom Pharmaceuticals

Current Roles

Employees:
399
Revenue:
$14.9M
About
Phathom Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of novel treatments for gastrointestinal (GI) diseases and disorders. The company is advancing the investigational agent vonoprazan, a novel potassium-competitive acid blocker (P-CAB). Vonoprazan has the potential to address multiple unmet needs among patients with gastroesophageal reflux disease (GERD) and other acid-related disorders. We have created a nimble, entrepreneurial environment that fosters the spirit of collective ownership, accountability, proprietorship and achievement ᅢᄁ¬ツᆲ¬タン elements that are key to our success.
Phathom Pharmaceuticals Address
100 Campus Drive
Florham Park, null

Past Companies

Phathom PharmaceuticalsVP, Head of Pharmacovigilance Services and Medical Informatics
Phathom PharmaceuticalsSenior Director, Medical and Scientific Services
TakedaSenior Director, Global Program Management, R&D Marketed Products

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.